A number of other research analysts also recently issued reports on DLHTF. National Bank Financial decreased their price objective on Dialogue Health Technologies from C$8.50 to C$6.75 in a report on Wednesday. Scotiabank reduced their target price on Dialogue Health Technologies from C$8.00 to C$5.50 in a research note on Wednesday. Royal Bank of Canada decreased their price objective on Dialogue Health Technologies from C$6.00 to C$5.00 in a report on Friday, September 23rd. Canaccord Genuity Group dropped their target price on Dialogue Health Technologies from C$6.00 to C$5.00 in a report on Wednesday. Finally, TD Securities reduced their target price on shares of Dialogue Health Technologies from C$4.50 to C$3.50 in a research report on Wednesday, September 21st.
Dialogue Health Technologies Trading Down 11.5 %
OTCMKTS:DLHTF opened at 2.07 on Wednesday. Dialogue Health Technologies has a 1-year low of 2.07 and a 1-year high of 4.75. The firm has a 50-day moving average of 2.09.
Dialogue Health Technologies Company Profile
Dialogue Health Technologies Inc operates a digital healthcare and wellness platform in Canada Germany, and Australia. Its Integrated Health Platform is a healthcare hub that centralizes its programs in a single user-friendly application, which provide access to psychologists, psychotherapists, social workers, physicians, nurses, and health specialists.
- Get a free copy of the StockNews.com research report on Dialogue Health Technologies (DLHTF)
- Does ASML’s November Rally Have Staying Power?
- Verra Mobility Stock Has Returned Back to the Station
- Is Advance Auto Parts a Buy After its Earnings Crash?
- BJ’s Wholesale Club: Beware The Sell-Side
- The Next Catalyst For Mullen Automotive Stock Is December 23rd
Receive News & Ratings for Dialogue Health Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dialogue Health Technologies and related companies with MarketBeat.com's FREE daily email newsletter.